help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traish, A. M.
Right arrow Articles by Goldstein, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traish, A. M.
Right arrow Articles by Goldstein, I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*ESTRADIOL
*TESTOSTERONE
Medline Plus Health Information
*Hormone Replacement Therapy
Endocrinology Vol. 140, No. 4 1861-1868
Copyright © 1999 by The Endocrine Society


ARTICLES

Effects of Castration and Androgen Replacement on Erectile Function in a Rabbit Model1

Abdulmaged M. Traish, Kwangsung Park, Vinita Dhir, Noel N. Kim, Robert B. Moreland and Irwin Goldstein

Departments of Urology (A.M.T., K.P., V.D., N.N.K., R.B.M., I.G.) and Biochemistry (A.M.T.), Boston University School of Medicine, Boston, Massachusetts 02118

Address all correspondence and requests for reprints to: Abdulmaged M. Traish, Ph.D., Professor of Biochemistry & Urology, Department of Urology, Center for Advanced Biomedical Research, Boston University School of Medicine, 700 Albany Street, Room W607, Boston, Massachusetts 02118. E-mail: atraish{at}bu.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We investigated, in a rabbit model, the effects of castration and testosterone replacement on: 1) the hemodynamics of the corpus cavernosum; 2) {alpha}-1 adrenergic receptor protein expression; 3) neural NO synthase protein expression and activity; 4) phosphodiesterase type 5 activity; and 5) trabecular smooth muscle/connective tissue balance. One week after bilateral orchiectomy, animals were treated for 7 days with vehicle alone, testosterone, or estradiol. Intact control animals received vehicle only. Systemic arterial blood and intracavernosal pressures (ICP) were measured in each animal before and after electrical stimulation of the cavernosal nerve. {alpha}1-adrenergic receptor protein expression was determined by ligand binding studies. NO synthase expression and activity were determined by Western blot analyses and conversion of L-arginine to citrulline, respectively. Phosphodiesterase type 5 activity was determined by hydrolysis of guanosine 3',5'-cyclic monophosphate (cGMP) in tissue extracts in the absence or presence of 100 nM sildenafil. Smooth muscle content was assessed by Masson’s trichrome staining and computer-assisted histomorphometry. Castration significantly reduced ICP, but it did not alter systemic arterial blood pressure during stimulation of the cavernosal nerve. Testosterone, but not estradiol, treatment prevented the effects of castration and restored ICP to values similar to those obtained in intact animals. Castration reduced expression of {alpha}1-adrenergic receptor, and this reduction was prevented or reversed by testosterone replacement. Neural NO synthase protein expression and total activity were not altered significantly by castration or after testosterone replacement. However, phosphodiesterase type 5 activity increased in castrated animals treated with testosterone. Castration significantly reduced trabecular smooth muscle content, and this reduction was restored by testosterone (but not estradiol) treatment. The results of this study demonstrate that androgen deprivation alters the functional responses and structure of erectile tissue.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ANDROGENS PLAY an important role in development of male secondary sexual characteristics, and androgen deficiency may result in structural abnormalities of the penis (1, 2, 3). Androgen depletion via surgical or medical castration generally results in loss of libido and decline in erectile function (3, 4, 5). Androgen treatment of hypogonadal men has been shown to restore sexual interest and activity (1, 3). Antiandrogen treatment of prostate cancer patients is associated with impairment of erectile function (5, 6); however, the mechanism by which androgens modify erectile function is a subject of considerable controversy (see Ref. 1).

During erection, the penis acts as a capacitor, accumulating blood under pressure (7, 8, 9). Dilation of the resistance arterial bed of the penis provides flow and pressure to the corpora, and relaxation of the trabecular smooth muscle allows expansion of the lacunar spaces and trapping of blood by compression of the draining venules (7, 8, 9). When corpus cavernosum smooth muscle is fully relaxed, the intracavernosal pressure (ICP) is dependent on the cavernosal arterial pressure. Trabecular smooth muscle is an important structure in the penis, which contributes to control of detumescence and erection (7). Neurotransmitters and vasoactive substances, such as NO, mediate the local control of trabecular smooth muscle tone. Erectile function is, therefore, dependent on the integrity of corpus cavernosum structure and the integration and regulation of functional interplay between neuroeffectors and vasoactive agents and their receptors (7, 8). Any imbalance in smooth muscle connective tissue ratio (10) or the integration of signal transduction caused by changes in receptor expression or function or down-stream events may result in erectile dysfunction (7, 8). Androgen deprivation may alter trabecular smooth muscle content or neurotransmitters and their receptors, resulting in altered function.

In the rat model, erection is androgen dependent (1, 11, 12). In castrated rats, ICP was reduced in response to electrical field stimulation of the cavernosal nerve. Testosterone treatment of castrated rats restored this response, suggesting androgen dependence of erectile function (11). The primary action of androgens in erectile function in the rat is postulated to be via stimulation of NO synthesis (11, 12, 13, 14, 15, 16). Neural NO synthase (NOS) messenger RNA and protein expression were reduced in castrated rats (13, 17); however, other studies demonstrated that neural NO synthase protein expression was not reduced but NOS activity was diminished (18, 19). Castration also reduced NOS containing nerve fibers, innervating corpus cavernosum tissue, and enhanced nonadrenergic noncholinergic (NANC) nerve-mediated relaxation in isolated corpus cavernosum strips and increased the reactivity to {alpha}-adrenergic stimulation (11). In addition, castration induced programmed smooth muscle cell death in the rat penis, suggesting that androgens may have an important role in maintaining smooth muscle growth and functional integrity (3). In the rabbit model, corpus cavernosum strips from castrated animals exhibited greater relaxation to electrical field stimulation than cavernosal strips from intact animals (20). However, the relaxation to exogenous NO donors was similar in cavernosal strips from castrated and intact animals (20). Tissue strips from intact rabbits showed a greater degree of contraction than tissue from castrated animals, suggesting changes in the adrenergic pathway in response to androgen deprivation (21). Though it was reported in the rat model that NANC nerve fibers are reduced by castration (16), these fibers were thought to be increased in the castrated rabbit model (20), suggesting differences in the response to androgens among species.

Most of the studies on the role of androgens on erectile function have focused on the effects of androgens on altering the expression or activity of NO synthase in the rat. Although the NO/cGMP pathway is an important regulator of smooth muscle contractility, penile erectile function is dependent on the balance and integration of multiple physiological functional control systems, including neurotransmitters, vasoactive agents, endocrine factors, and tissue fibroelastic properties. Thus, although the effects of androgens on NO synthase have been investigated in the rat, the effects of androgens on the smooth muscle/connective tissue balance and possible alteration of corporal veno-occlusive mechanisms have yet to be investigated.

The goal of this study was to investigate the effects of androgen depletion and androgen replacement in a rabbit model on: 1) the hemodynamics of erectile tissue in vivo; 2) the expression of {alpha}1 adrenergic receptors; 3) neural NO synthase; 4) phosphodiesterase type 5 activity; and 5) smooth muscle content of corpus cavernosum.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
[125I]HEAT (2-{ß-(4-hydroxy-3-[125I]iodophenyl)-ethylaminomethyl}-tetralone ([125I]HEAT) (~ 2000 Ci/mmol), L-[14C]arginine (300 µCi/mmol), and 8-[3H]cGMP (7.64 Ci/mmol) were obtained from New England Nuclear, Boston, MA. Unlabeled prazosin, phenylmethylsulfonyl fluoride, aprotinin, and pepstatin A were obtained from Sigma Chemical Co. (St. Louis, MO). All other chemicals were reagent grade and were obtained from commercial sources. Enhanced chemoluminescence (ECL) Western blot detection kits were obtained from Pierce Chemical Co. (Rockland, IL).

Animal castration and androgen replacement
The Animal Care Committee of the Boston University School of Medicine approved this study. New Zealand white male rabbits (3–3.5 kg) were divided into four groups (nine animals per group). One group was kept intact (controls). The remaining groups of animals were bilaterally castrated through 3-cm scrotal incisions, under anesthesia. One week post orchiectomy, the animals were either injected with vehicle (benzoylbenzoate: castor oil, 1:4) daily for 7 days (vehicle) or injected sc daily with testosterone (14 mg/day) or estradiol (14 mg/day) dissolved in vehicle.

Measurements of systemic arterial blood and ICPs
Animals were anesthetized with im injections of ketamine (35 mg/kg) and xylazine (5 mg/kg). Anesthesia was maintained with 0.2 ml iv bolus injection of pentobarbital (25 mg/ml), as needed. A 20-gauge angiocatheter was placed into the carotid artery for measurement of systemic arterial blood pressure. A 21-gauge minicatheter was placed intracavernosally for measurement of ICP. A midline abdominal incision was made to expose the perivesical space. The internal pudendal artery was identified; and the distal branch to the prostate, bladder neck, and cavernosal bodies was localized. The cavernosal nerve bears relation to the cavernosal artery on the posterolateral surface of the prostate. Using platinum wire electrodes, we electrically stimulated the cavernosal nerve at varying frequencies (1–25 Hz) with a train of square waves at 10 V and a pulse width of 8 msec for a total duration of 30–60 sec.

Measurements of {alpha}1-adrenergic receptors in corpus cavernosum membranes
Rabbit corpus cavernosum membranes were prepared as previously reported (22). Alpha adrenergic receptor binding studies were carried out using [125I]HEAT as a ligand, and nonradioactive prazosin as unlabeled competitor, as described previously (22, 23). Protein-bound radioactivity was determined by filtration assay, and the specific binding was determined by subtraction of nonspecific binding and was normalized, per milligram DNA, to correct for possible loss of DNA caused by programmed cell death that may take place subsequent to castration (3).

Determination of neural NO synthase expression by Western blot analyses
Neural NO synthase protein expression in corpus cavernosum was carried out by Western blot analyses using isoform-specific monoclonal antibodies (Transduction Research, Paducah, KY). Rabbit corpus cavernosum tissue was homogenized, and the homogenates were centrifuged at 800 x g for 30 min at 4 C, to obtain crude cytosolic extracts. Aliquots of each extract were assayed for protein concentration by the method of Lowry. Identical amounts of protein (100 µg total protein/lane) from each extract were electrophoresed on 7.5% SDS polyacrylamide gels. After transfer to nitrocellulose membranes, samples were incubated with mouse antirat neural NOS monoclonal antibody. Membranes were washed and incubated with horseradish peroxidase-linked goat antimouse IgG (secondary antibody, Pierce Chemical Co.). Membranes were developed with an ECL kit and exposed to autoradiography film (Hyperfilm; Amersham Corp., Arlington Heights, IL) to obtain visible bands at 160 kDa. Rat pituitary lysate was used as positive control (10 µg/lane; rat neural NO synthase). The bands were scanned by densitometry, and the values obtained were normalized, per milligram protein, or mg DNA.

Determination of NO synthase activity
NO synthase activity in the total tissue extract was determined by conversion of L-[14C]arginine to [14C]citrulline and NO, as described by Kim et al. (24). Briefly, aliquots of the tissue extract were incubated with tetrahydrobiopterin (3 µM), calmodulin (30 U/ml), L-arginine (50 µM), [14C] L-arginine (2µCi/ml), NADPH (20 mM), and calcium chloride (1 mM) at 37 C for 45 min. Parallel samples were incubated at 2 C. Citrulline was separated from arginine by ion exchange columns (1 ml) of AG50W-X8 resin (Bio-Rad Laboratories, Inc., La Jolla, CA) and quantified by scintillation counting of radioactivity. Enzymatic activity was expressed as µM of citrulline per mg protein or ug DNA per 45 min.

Assay of phosphodiesterase type 5 activity
Phosphodiesterase activity assays were carried out as described previously (25, 26). Briefly, aliquots (50 µl, in triplicates) of cytosol were incubated at 30 C for 30 min in the presence of unlabeled cGMP (1 µM) and [3H]cGMP (50 nM), in 40 mM 4-morpholine propane sulfonic acid buffer, 0.8 mM EGTA, 5 mM Mg acetate, 0.2 mg/ml BSA (pH 7.0), with or without 100 nM sildenafil (phosphodiesterase type 5 selective inhibitor), in a final vol of 250 µl. Parallel incubations were made, in the absence of cytosol, to serve as control (blank). The reactions were terminated by incubation, at 100 C for 1 min, to inactivate the enzyme. The reaction mixtures were incubated with 2.5 µl of 10 mg/ml Crotalus atrox venom, to hydrolyze GMP to guanine, for 10 min at 30 C (25, 26). Deionized water (0.5 ml) was added to each sample, and the total incubation mixture was chromatographed on an ion exchange resin (DEAE Sephadex A-25), preequilibrated with 20 mM Tris-HCl, pH 7.5. Hydrolyzed guanine was eluted with 3 ml of 20 mM Tris-HCl buffer directly into scintillation vials, and the column retained the unhydrolyzed GMP and cGMP. Liquiscint (10 ml) was added to each vial, and the radioactivity was counted. The radioactivity representing spontaneous cGMP hydrolysis, determined from the control (blank) incubation, was considered background activity and was subtracted from radioactivity determined in each sample. The concentration of cGMP hydrolyzed by phosphodiesterase type 5 was determined for each sample, normalized for isotope dilution protein and DNA concentrations.

Determination of smooth muscle/connective tissue ratio by histomorphometry
We carried out, in a blinded fashion to the animal treatment, histomorphometric analyses to determine the relative content of smooth muscle vs. connective tissue in corpus cavernosum, as described previously (27, 28). Briefly, after ICP measurements in response to nerve stimulation, the penis was removed en bloc, and the corpus cavernosum tissue was dissected. Tissues were fixed, paraffin-embedded, sectioned, and stained with Masson’s trichrome (27, 28). We used computer-assisted color histomorphometry to assess the mean percentage of the trabecular smooth muscle to total erectile tissue (smooth muscle plus connective tissue). Sections from proximal, distal, and medial region of the penis of each animal were examined. For each tissue section, 10–15 fields (400 x magnification) were examined; and the smooth muscle content was assessed using image analysis software to quantitate areas stained red (smooth muscle) and areas stained blue (connective tissue).

Statistical analyses
Where applicable, data were analyzed by ANOVA, followed by two-tailed Student’s t test, for comparison between two groups with appropriate Bonferroni corrections. Data were considered statistically significant when P values were less than 0.02. However, for any given set of experiments, we reported lower P values to indicate actual levels of significance.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effects of castration and androgen replacement on nerve-stimulated penile erection
Figure 1Go demonstrates that androgen deprivation resulted in no changes in systemic systolic and diastolic blood pressure in all animal treatment groups. ICP in the flaccid state remained unchanged for all groups. ICP, after electrical stimulation of the pelvic nerve, however, was significantly reduced in the castrated animal groups treated with vehicle only (Fig. 1Go, lower panel, V) and in castrated animals treated with estradiol (Fig. 1Go, lower panel, E). Testosterone treatment of castrated animals (Fig. 1Go, lower panel, T) reversed the effects of castration and restored it to control levels (Fig. 1Go, lower panel, C).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 1. Effects of castration and androgen replacement on nerve-stimulated penile erection. Upper panel, A representative tracing of the ICP in response to electrical field stimulation of the pelvic nerve; middle panel, mean systemic arterial pressure; lower panel, the changes in ICP in the various treatment groups (C, intact control animals; V, castrated treated with vehicle only; T, castrated treated with testosterone; E, castrated treated with estradiol) before (flaccid state) and during penile nerve stimulation (PNS; erect state). The data are the mean ± SEM (n = 9 for each treatment group); *, Statistical significance.

 
Effects of castration and androgen replacement on the expression of {alpha}1-adrenergic receptors in rabbit corpus cavernosum
Studies in organ bath chambers suggested that corpus cavernosal tissue from intact animals showed greater contraction to the {alpha}1-adrenergic agonist than tissue strips from castrated animals (1). We investigated the effects of androgen deprivation and androgen replacement on the expression of {alpha}1-adrenergic receptor. As shown in Fig. 2Go, the concentration of {alpha}1-adrenergic receptor functional protein (fmol/mg DNA) was reduced significantly in corpus cavernosum of castrated animals and was restored to control levels in castrated animals treated with testosterone.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. Effects of castration and androgen replacement on the expression of {alpha}1-adrenergic receptors in the corpus cavernosum. Crude membrane preparations of corpus cavernosum tissue from control (C) and castrated rabbits treated with vehicle (V) or testosterone (T) were used for binding assay using [125I]HEAT as a ligand, as described in Materials and Methods. Nonspecific binding was determined by inclusion of 1 µM unlabeled prazosin in the incubation. Only specific binding is represented. The data were normalized, per milligram DNA, to account for cellular loss in the cavernosal tissue in castrated animals. *, Significant difference (P < 0.02; n = 9) from control.

 
Effects of castration and androgen replacement on expression and activity of neural NO synthase in rabbit corpus cavernosum
When equal amounts of corpus cavernosum crude cytosolic proteins were analyzed by Western blots, a slight increase in neural NO synthase protein expression was observed in cytosols from castrated animals or castrated, estrogen-treated animals (Fig. 3Go). When the band densities were normalized on a DNA basis, a similar increase in neural NO synthase protein expression was noted in castrated animals and castrated estrogen-treated animals (Fig. 4Go). However, these differences were not significantly different from control (P > 0.02).



View larger version (29K):
[in this window]
[in a new window]
 
Figure 3. Effects of castration and androgen replacement on expression of neural NO synthase (nNOS) in the corpus cavernosum. Equal amounts of corpus cavernosum crude cytosols from each treatment group were analyzed by 7.5% SDS PAGE and subjected to Western blot analysis using neural NO synthase-specific monoclonal antibodies and detected using ECL. Duplicate lanes are shown, representing samples from two different animal experiments. Rat neural NO synthase was used as positive control. MW, Molecular weight.

 


View larger version (32K):
[in this window]
[in a new window]
 
Figure 4. Effects of castration and androgen replacement on the expression of neural NO synthase in the corpus cavernosum. Bands detected by Western blot, shown in Fig. 3Go, were scanned; and the optical density of bands generated from each treatment group was normalized, per milligram protein (upper panel) or milligram DNA (lower panel).

 
Measurements of total NOS activity in corpus cavernosum cytosols from castrated animals showed no significant decrease of NOS activity, when compared with cytosols from intact or castrated testosterone-treated animals (Fig. 5Go). Although a marked increase in NOS activity was observed in castrated animals treated with estradiol, these changes were not statistically significant (P > 0.02). These observations suggest that, in contrast to the rat model, androgen deprivation does not significantly alter neural NO synthase protein expression or activity in the rabbit corpus cavernosum.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 5. Effects of castration and androgen replacement on NO synthase activity in the corpus cavernosum. NO synthase activity was determined by formation of L-citrulline from L-arginine, as described in Materials and Methods. Crude cytosols from corpus cavernosal tissue, derived from each treatment group, was pooled and assayed for NOS activity. The activity was normalized, per milligram protein/per 45 min or per milligram DNA per 45 min. The data represents the average of two independent experiments (C, intact control animals; V, castrated treated with vehicle only; T, castrated treated with testosterone; E, castrated treated with estradiol).

 
Effects of castration and androgen replacement on phosphodiesterase type 5 activity in rabbit corpus cavernosum
Measurements of phosphodiesterase type 5 activity in corpus cavernosum cytosols from castrated animals showed no significant changes in phosphodiesterase type 5 activity, when compared with cytosols from intact animals. In contrast, when data were normalized on a DNA basis, a significant increase (P < 0.02) in phosphodiesterase type 5 activity was observed in cytosols from castrated testosterone-treated animals (Fig. 6Go).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6. Effects of castration and androgen replacement on phosphodiesterase type 5 (PDE5) activity in the corpus cavernosum. Phosphodiesterase type 5 activity was determined by cGMP hydrolysis, as described in Materials and Methods. The data represent the average of two independent experiments (C, intact control animals; V, castrated treated with vehicle only; T, castrated treated with testosterone; E, castrated treated with estradiol). *, Significant difference from control (P < 0.02; n = 9).

 
Effects of castration and androgen replacement on smooth muscle content in rabbit corpus cavernosum
Castration reduced trabecular smooth muscle content, as indicated by decreased smooth muscle (staining red) and increased staining of connective tissue (staining blue) (Fig. 7Go, panel V), when compared with controls (panel C). Androgen replacement (panel T) prevented smooth muscle loss and maintained the smooth muscle staining, comparable to that observed in control animals (panel C). Estradiol (panel E) did not prevent the effects of castration. These changes were assessed quantitatively by computer-assisted histomorphometric analyses of corpus cavernosum tissue sections from control (C), castrated rabbits, treated with vehicle only (V), castrated rabbits treated with testosterone (T), and castrated rabbits treated with estradiol (E). The data in Fig. 8Go confirmed the qualitative histologic observations.



View larger version (150K):
[in this window]
[in a new window]
 
Figure 7. Effects of castration and androgen replacement on trabecular smooth muscle and connective tissue content in the corpus cavernosum. Corpus cavernosum tissue, from the various treatment groups, was fixed and stained with Masson’s trichrome and processed for quantitative histomorphometry. Representative sections from each treatment group are shown: C, intact control; V, castrated treated with vehicle only; T, castrated treated with testosterone; and E, castrated treated with estradiol (magnification, 200 x).

 


View larger version (17K):
[in this window]
[in a new window]
 
Figure 8. Effects of castration and androgen replacement on trabecular smooth muscle and connective tissue content in the corpus cavernosum. Quantitative changes in trabecular smooth muscle content, determined by computer-assisted histomorphometry, are shown for each treatment group, as described in Fig. 7Go. The data are the mean ± SEM (n = 9 for each treatment group). *, Significant differences from control group (P < 0.02).

 
Castration resulted in a statistically significant loss of trabecular smooth muscle (P < 0.02), when compared with control. Testosterone treatment prevented the loss of smooth muscle induced by castration. Estradiol treatment (E), however, did not prevent the loss of trabecular smooth muscle, as indicated by the significant decrease, compared with control (P < 0.02).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Penile erectile function is dependent on the balance and integration between multiple physiological, functional, and overlapping control systems, including neurotransmitters, vasoactive agents, and endocrine factors (7, 29). In addition, erectile function is dependent on tissue structure and fibroelastic properties of the corpus cavernosum (27, 28). In the rat, it has been reported that androgens modulate erectile function (1, 3, 11, 12, 13, 14, 15, 16, 17, 18), and several studies have demonstrated expression of androgen receptors in penile corpus cavernosum tissue (30, 31, 32). However, the exact molecular mechanism of androgen action in erectile function remains unknown (1). Identification and characterization of androgen receptors in the rabbit penis has yet to be reported. Nevertheless, the effects of androgens in rabbit penile function are probably mediated via nuclear androgen receptors in the various androgen target anatomical sites regulating erectile function.

The effect of androgens on erectile function is complex, and androgens may influence not only the central nervous system but also affect the peripheral nervous system and penile erectile tissue (1). Several studies have pointed to androgen regulation of neurotransmitters in erectile function. Androgens were reported to regulate NO synthase in neurons of the major pelvic ganglion in the rat (17). Androgen receptors also colocalize with NO synthase and vasoactive intestinal polypeptide in the major pelvic ganglion of the rat penis (33). Androgens modulate programmed trabecular smooth muscle cell death (apoptosis) in rat penile tissue (3), suggesting a direct effect of androgens on cavernosal smooth muscle and trabecular tissue structure. Thus, androgens may affect erectile function by acting at different sites. The exact mode of androgen action in regulation of erectile function remains unknown.

In this study, we have investigated the effects of androgen depletion and replacement on the functional responses of erectile corpus cavernosum, by assessment of hemodynamic changes produced in response to electrical field stimulation of the cavernosal nerve and biochemical and histological parameters. Androgen deprivation did not affect the systemic arterial blood pressure in castrated animals or in castrated animals treated with testosterone or estradiol. However, ICP, which is indicative of erectile function, was significantly reduced by androgen deprivation and was restored to control levels by testosterone (but not by estradiol) treatment. The results suggested that androgens had altered either the synthesis or release of neurotransmitters, receptor function, or tissue structure, and therefore altered the reactivity of the corpus cavernosum. In the castrated rabbits, stimulation of the cavernosal nerve resulted in attenuated erection, suggesting that androgens are critical for maintaining the neural/smooth muscle functional and metabolic integrity.

Androgens may affect neurotransmitter synthesis, release, or neurotransmitter receptor density or distribution on the trabecular smooth muscle, thus altering tissue responsiveness (11). In this study, we focused mainly on effects of castration and androgen replacement on expression of functional {alpha}1-adrenergic receptors but made no attempts to examine the changes in neurotransmitter synthesis or release. We observed that castration reduced the density of functional {alpha}1-adrenergic receptor in the corpus cavernosum smooth muscle. Androgen replacement restored {alpha}1-adrenergic receptor levels to those of control animals. Because {alpha}1- adrenergic receptors mediate the contractile response, one would expect the decrease in the density of {alpha}1-adrenergic receptors, subsequent to castration, to attenuate smooth muscle contraction and enhance nerve-stimulated penile erection. However, we observed attenuation of nerve-stimulated penile erection in the castrated animals. This observation suggests that androgens affect the trabecular smooth muscle function via other mechanisms, which may include structural changes, and reduced synthesis, and release of vasoactive factors.

Alternatively, androgens may influence the activity of the NANC neurotransmitter or down-stream signal transduction pathways, and/or the reactivity of the trabecular smooth muscle, to neurotransmitters (13, 14, 15, 16, 17, 18). In the rabbit corpus cavernosum, castration did not reduce neural NO synthase protein expression or activity when normalized on protein or DNA basis. This finding is in contrast to previous reports in the rat penis (14) in which castration resulted in reduced neural NO synthase messenger RNA and protein expression.

Upon cavernosal nerve stimulation, NO released from the nonadrenergic, noncholinergic nerves activate guanylyl cyclase and increase intracellular cGMP synthesis. This increase in intracellular cGMP modulates intracellular calcium, which, in turn, regulates smooth muscle contractility and erectile function (34). Phosphodiesterase type 5 plays an important physiological role by regulating the intracellular levels of cGMP and smooth muscle relaxation (25, 34). Castration did not significantly reduce phosphodiesterase type 5 activity in erectile tissue of the rabbit; however, androgen replacement produced a significant increase in phosphodiesterase type 5 activity, when normalized on DNA basis. Though the implication of this observation in not clear, at present, it may relate to the complex regulation of neural NO synthase and phosphodiesterase type 5 by androgens in this tissue.

Penile erection depends on a functional veno-occlusive mechanism (9, 10, 27, 28), which requires a critical balance between trabecular smooth muscle and connective tissue (10, 27, 28). If androgen deprivation results in programmed trabecular smooth muscle cell death and an imbalance in this critical ratio, one would expect failure of the veno-occlusive mechanism and impairment of erectile function. In this study, we determined the effects of castration and androgen replacement on the balance between smooth muscle and connective tissue content. We noted a significant decrease in the content of trabecular smooth muscle in castrated rabbits and in castrated animals treated with estradiol. Treatment of castrated animals with testosterone restored smooth muscle content to those of control animals. Because the data obtained with castrated animals treated with vehicle only were similar to those obtained with castrated animals treated with estradiol, we suggest that administration of estradiol did not prevent the loss of trabecular smooth muscle; nor did it result in its restoration, suggesting androgen specificity of this process. However, a role for estrogens in maintaining smooth muscle growth or function cannot be ruled out at this time (see below). These observations are consistent with the marked decreases in the ICPs (loss of erectile function), after cavernosal nerve stimulation in castrated animals treated with vehicle only or with estradiol.

To relate the observed effects of androgens on erectile tissues, we used estradiol, a nonandrogen steroid, which cannot be converted back to androgens in vivo. For this reason, this study did not attempt to address specifically the role of estrogen in erectile function. Nevertheless, several studies suggest that estradiol may have different effects in different animal species. In one study, no significant differences in behavior of animals treated with vehicle and estradiol were reported (35), suggesting that estradiol had no effect on maintaining sexual activity. In another study, estrogen failed to return penile responsiveness after castration in rats (36). Estradiol, however, was shown to be sufficient to activate copulatory behavior in male rats (37) and further restored sexual behavior in castrated male rats (38). Whether estrogens play a role in erectile function in the rabbit remains unknown.

The results of this study suggest that androgen deprivation results in marked reduction of ICP, {alpha}-adrenergic receptors, and smooth muscle content. Androgen replacement restored these changes to control levels. Androgen deprivation may contribute to impairment of the functional veno-occlusive mechanism and reduced erectile function.


    Acknowledgments
 
The authors are grateful to Dr. K. Azadzoi for his assistance with animal castration and hemodynamic measurements. We thank Ms. Yue-Hua Huang and Cynthia Gallant for their technical assistance, and Ms. Jerie McGrath-Cerqua for her administrative assistance.


    Footnotes
 
1 This work was supported by NIH Grants DK-39080, DK-40025, and DK-47950. Back

Received September 1, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Mills TM, Reilly CM, Lewis RW 1996 Androgens and penile erection: a review. J Androl 17:633–638[Free Full Text]
  2. Baskin LS, Sutherland RS, DiSandro MJ, Hayward SW, Lipschultz J, Cunha GR 1997 The effect of testosterone on androgen receptors and human penile growth. J Urol 158:1113–1118[CrossRef][Medline]
  3. Shabsigh R 1997 The effects of testosterone on the cavernous tissue and erection. World J Urol 15:21–26[CrossRef][Medline]
  4. Yildrim MK, Yildrim S, Utkan T, Sarioglu Y, Yalman Y 1997 Effects of castration on adrenergic, cholinergic and nonadrenergic, noncholinergic responses of isolated corpus cavernosum from rabbit. Br J Urol 79:964–970[Medline]
  5. Rousseau L, Dupont A, Labrie F, Couture M 1988 Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration. Arch Sex Behav 17:87–98[CrossRef][Medline]
  6. Peters CA, Walsh PC 1987 The effect of nafarelin acetate, a luteinizing-hormone- releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 317:599–604[Abstract]
  7. Andersson K-E, Wagner G 1995 The physiology of penile erection. Physiol Rev 75:191–236[Free Full Text]
  8. Lue T, Dahiya M 1997 Molecular biology of erectile function and dysfunction. Mol Urol 1:35–48
  9. Udelson D, Nehra A, Hatzichristou D, Azadzoi A, Moreland RB, Krane RJ, Saenz de Tejada I, Goldstein I 1998 Engineering analysis of penile hemodynamic and structural dynamic relationships Part I—Clinical implications of penile tissue mechanical properties. Int J Impot Res 10:15–24[CrossRef][Medline]
  10. Moreland RB 1998 Is there a role for hypoxemia in penile fibrosis? Int J Impot Res 10:113–120[Medline]
  11. Reilly CM, Stopper VS, Mills TM 1997 Androgens modulate the alpha - adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. J Androl 18:26–31[Abstract/Free Full Text]
  12. Mills TM, Wiedmeir VT, Stopper VS 1992 Androgen maintenance of erectile function in the rat penis. Biol Reprod 46:342–348[Abstract]
  13. Chamness SL, Ricker DD, Crone JK, Dembeck CL, Maguire MP, Burnett AL, Chang TS 1995 The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 63:1101–1107[Medline]
  14. Garban H, Marquez D, Cai L, Rajfer J, Gonzalez-Cadavid NF 1995 Restoration of normal adult penile erectile response in aged rats by long-term treatment with androgens. Biol Reprod 53:1365–1372[Abstract]
  15. Lugg JA, Rajfer J, Gonzalez-Cadavid NF 1995 Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. Endocrinology 136:1495–1501[Abstract]
  16. Zvara P, Sioufi R, Schipper HM, Begin LR, Brock GB 1995 Nitric oxide mediated erectile activity is a testosterone dependent event: a rat erection model. Int J Impot Res 7:209–219[Medline]
  17. Schirar A, Bonnefond C, Meusnier C, Devinoy E 1997 Androgens modulate nitric oxide synthase messenger ribonucleic acid expression in neurons of the major pelvic ganglion in the rat. Endocrinology 138:3093–3102[Abstract/Free Full Text]
  18. Penson DF, Ng C, Cai L, Rajfer J, Gonzalez-Cadavid NF 1996 Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biol Reprod 55:567–574[Abstract]
  19. Lugg J, Ng C, Rajfer J, Gonzalez-Cadavid N 1996 Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity. Am J Physiol 271:E354–E361
  20. Holmquist F, Persson K, Bodker A, Anderson KE 1994 Some pre- and postjunctional effects of castration in rabbit isolated corpus cavernosum and urethra. J Urol 152:1011–1016[Medline]
  21. Baba K 1993 Effects of testosterone on smooth muscle in the isolated rabbit corpus cavernosum penis. Nippon Hinyokika Gakkai Zasshi 84:1783–1790[Medline]
  22. Traish AM, Toselli P, Gupta, S, Saenz de Tejada I, Goldstein I, Moreland RB 1995 Identification of {alpha}1-adrenergic receptor subtypes in human corpus cavernosum tissue and in cultured trabecular smooth muscle cells. Receptors 5:145–157
  23. Traish AM, Moreland RB, Huang Y-H, Goldstein I 1997 Expression of functional alpha-2-adrenergic receptor subtypes in human corpus cavernosum and in human corpus cavernosum smooth muscle cells. Recept Signal Transduct 7:55–67[Medline]
  24. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I 1993 Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 91:437–443
  25. Moreland RB, Goldstein I, Traish A M 1998 Characterization of type 5 phosphodiesterase activity in human corpus cavernosum smooth muscle cells: inhibition by sildenafil and zaprinast. Life Sci 62:PL309–PL318
  26. Park K, Moreland RB, Goldstein I, Atala A, Traish AM 1998 Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun 249:612–617[CrossRef][Medline]
  27. Nehra A, Goldstein I, Pabby A, de las Morenas A, Udelson D, Krane RJ, Saenz de Tejada I, Moreland RB 1996 Mechanisms of venous leak in erectile dysfunction in patients with vascular risks factors: a clincopathologic correlation of corporal veno-occlusion. J Urol 156:1320–1329[CrossRef][Medline]
  28. Nehra A, Azadzoi KM, Moreland RB, Pabby A, Siroky MB, Krane RJ, Goldstein I, Udelson DG 1998 Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol 159:2229–2236[CrossRef][Medline]
  29. Adams MA, Banting JD, Maurice DH, Morales A, Heaton JP 1997 Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems. Int J Impot Res 9:85–91[CrossRef][Medline]
  30. Gonzalez-Cadavid NF, Swerdloff RS, Lemmi CA, Rajfer J 1991 Expression of the androgen receptor gene in rat penile tissue and cells during sexual maturation. Endocrinology 129:1671–1678[Abstract]
  31. Takane KK, Husmann DA, McPhaul MJ, Wilson JD 1991 Androgen receptor levels in the rat penis are controlled differently in distinctive cell types. Endocrinology 128:2234–2238[Abstract]
  32. Nonomura K, Sakakibara N, Demura T, Mori T, Koyanagi T 1990 Androgen binding activity in the spongy tissue of mammalian penis. J Urol 144:152–155[Medline]
  33. Schirar A, Chang C, Rousseau JP 1997 Localization of androgen receptor in nitric oxide synthase- and vasoactive intestinal peptide-containing neurons of the major pelvic ganglion innervating the rat penis. J Neuroendocrinol 9:141–150[CrossRef][Medline]
  34. Moreland RB, Goldstein I, Kim NN, Traish AM Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: research and clinical implications in erectile function. Trends Endocrinol Metab, in press
  35. Michael RB, Zumpe D, Bonsall RW 1990 Estradiol administration and the sexual activity of castrated male rhesus monkeys. Horm Behav 24:71–88[CrossRef][Medline]
  36. Hart BL 1979 Activation of sexual reflexes of male rats by dihydrotestosterone but not estrogen. Physiol Behav 23:107–109[CrossRef][Medline]
  37. Meisel RL, O’Hanlon JK, Sachs BD 1984 Differential maintenance of penile responses and copulatory behavior by gonadal hormones in castrated male rats. Horm Behav 18:56–64[CrossRef][Medline]
  38. Kendrick KM, Drewett RF 1980 Testosterone sensitive neurons respond to estradiol but not dihydrotestosterone. Nature 286:67–68[CrossRef][Medline]



This article has been cited by other articles:


Home page
J AndrolHome page
A. L. Burnett
Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health
J Androl, January 1, 2008; 29(1): 3 - 14.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
N. Suzuki, Y. Sato, S.-I. Hisasue, R. Kato, K. Suzuki, and T. Tsukamoto
Effect of Testosterone on Intracavernous Pressure Elicited With Electrical Stimulation of the Medial Preoptic Area and Cavernous Nerve in Male Rats
J Androl, March 1, 2007; 28(2): 218 - 222.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. Armagan, N. N. Kim, I. Goldstein, and A. M. Traish
Dose-Response Relationship Between Testosterone and Erectile Function: Evidence for the Existence of a Critical Threshold
J Androl, July 1, 2006; 27(4): 517 - 526.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. N McMahon, C. J Smith, and R. Shabsigh
Treating erectile dysfunction when PDE5 inhibitors fail
BMJ, March 11, 2006; 332(7541): 589 - 592.
[Full Text] [PDF]


Home page
J AndrolHome page
V. Rochira, A. Balestrieri, B. Madeo, A. R. M. Granata, and C. Carani
Sildenafil Improves Sleep-Related Erections in Hypogonadal Men: Evidence From a Randomized, Placebo-Controlled, Crossover Study of a Synergic Role for Both Testosterone and Sildenafil on Penile Erections
J Androl, March 1, 2006; 27(2): 165 - 175.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. M. Traish, P. Toselli, S.-J. Jeong, and N. N. Kim
Adipocyte Accumulation in Penile Corpus Cavernosum of the Orchiectomized Rabbit: A Potential Mechanism for Veno-occlusive Dysfunction in Androgen Deficiency
J Androl, March 1, 2005; 26(2): 242 - 248.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. Tosti, M. Pazzaglia, M. Soli, A. Rossi, A. Rebora, L. Atzori, M. Barbareschi, M. Benci, S. Voudouris, and G. A. Vena
Evaluation of Sexual Function With an International Index of Erectile Function in Subjects Taking Finasteride for Androgenetic Alopecia
Arch Dermatol, July 1, 2004; 140(7): 857 - 858.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Morelli, S. Filippi, R. Mancina, M. Luconi, L. Vignozzi, M. Marini, C. Orlando, G. B. Vannelli, A. Aversa, A. Natali, et al.
Androgens Regulate Phosphodiesterase Type 5 Expression and Functional Activity in Corpora Cavernosa
Endocrinology, May 1, 2004; 145(5): 2253 - 2263.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. Musicki, M. A. Palese, J. K. Crone, and A. L. Burnett
Phosphorylated Endothelial Nitric Oxide Synthase Mediates Vascular Endothelial Growth Factor-Induced Penile Erection
Biol Reprod, February 1, 2004; 70(2): 282 - 289.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. E. DiSanto
Corpus Cavernosum Smooth Muscle Physiology: A Role for Sex Hormones?
J Androl, November 1, 2003; 24(6_suppl): S6 - S16.
[Full Text] [PDF]


Home page
J AndrolHome page
M. A. Palese, J. K. Crone, and A. L. Burnett
A Castrated Mouse Model of Erectile Dysfunction
J Androl, September 1, 2003; 24(5): 699 - 703.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda and T. Okamura
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. J. Wingard, J. A. Johnson, A. Holmes, and A. Prikosh
Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1572 - R1579.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. M. Traish, R. Munarriz, L. O'Connell, S. Choi, S. W. Kim, N. N. Kim, Y.-H. Huang, and I. Goldstein
Effects of Medical or Surgical Castration on Erectile Function in an Animal Model
J Androl, May 1, 2003; 24(3): 381 - 387.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traish, A. M.